Ventripoint Receives Market Clearance from US-FDA for Complete Heart Analysis System using 2D Ultrasound

Tickers: XTSX:VPT, PINX:VPTDFTags: Heathcare, Technology Toronto, Ontario / TheNewswire / May 15, 2018 – Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company") (TSXV:VPT) announces that it has received market clearance from the US Food and Drug Administration ("FDA") to sell its…